Zobrazeno 1 - 10 of 21 pro vyhledávání: '"Christopher J. Rabbat"'
1
Akademický článek
Local adverse reaction rates decreased over time during treatment with recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin G (fSCIG) in patients with primary immunodeficiency diseases in the fSCIG phase 3 studies
Autor: Lina Laguado, Mark Stein, Richard L. Wasserman, Isaac Melamed, Sudhir Gupta, Lisa Kobrynski, Arye Rubinstein, Christopher J. Rabbat, Werner Engl, Barbara McCoy, Heinz Leibl, Leman Yel
Publikováno v: Revista Alergia México, Vol 65 suppl 1, Pp 122-123 (2018)
Background: fSCIG can be administered at similar doses/volumes and dosing intervals as intravenous immunoglobulin G (IgG) (IVIG) but, similar to conventional subcutaneous IgG, is associated with a lower risk of systemic and higher risk of local adver
Externí odkaz: https://doaj.org/article/9aae66591f9d43e2bb416689d3ba4a8f
Zobrazit plný text záznamu
2
Akademický článek
Non-interventional post-marketing safety study on the long-term safety of HyQvia (global)
Autor: Lina Laguado, Katharina Fielhauer, Andras Nagy, Christopher J. Rabbat, Barbara McCoy, Heinz Leibl, Leman Yel
Publikováno v: Revista Alergia México, Vol 65 suppl 1, p 133 (2018)
Background: We describe the design of a non-interventional, prospective, uncontrolled, multicenter, open-label, post-marketing surveillance study to be conducted in the US and other countries where recombinant human hyaluronidase (rHuPH20)-facilitate
Externí odkaz: https://doaj.org/article/0f6a7cf061704ddab81e8c5d4042af84
Zobrazit plný text záznamu
3
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE)
Autor: William J Sandborn, Séverine Vermeire, Laurent Peyrin-Biroulet, Marla C Dubinsky, Julian Panes, Andres Yarur, Timothy Ritter, Filip Baert, Stefan Schreiber, Sheldon Sloan, Fabio Cataldi, Kevin Shan, Christopher J Rabbat, Michael Chiorean, Douglas C Wolf, Bruce E Sands, Geert D'Haens, Silvio Danese, Martina Goetsch, Brian G Feagan
Publikováno v: The Lancet, 401(10383), 1159-1171. Elsevier Limited
BACKGROUND: Etrasimod, a once-daily, oral, sphingosine 1-phosphate (S1P) receptor modulator that selectively activates S1P receptor subtypes 1, 4, and 5, with no detectable activity on S1P2,3, is in development for the treatment of immune-mediated di
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b22039216d6869860ce8021f4579b0
https://doi.org/10.1016/s0140-6736(23)00061-2
Zobrazit plný text záznamu
6
Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases
Autor: Richard L Wasserman, Sudhir Gupta, Mark Stein, Christopher J Rabbat, Werner Engl, Heinz Leibl, Leman Yel
Publikováno v: Immunotherapy.
Aim: This post hoc analysis evaluated the efficacy and overall tolerability of immunoglobulin (Ig) treatment modalities (intravenous Ig [iv.Ig], subcutaneous Ig [sc.Ig] and facilitated sc.Ig [fsc.Ig]). Materials & methods: A total of 30 participants
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82d474c8bf509fedc59857abafe98a64
https://doi.org/10.2217/imt-2021-0256
Zobrazit plný text záznamu
8
A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay)
Autor: Leman Yel, Christopher J. Rabbat, Jesper Nymann-Andersen, Jordan S. Orange, Troy R. Torgerson, Maoyong Fu, Marc S. Edwards, Yeong Wang, James W. Verbsky, Terry S. Robins, Charlotte Cunningham-Rundles
Publikováno v: Journal of Clinical Immunology
Yel, L; Rabbat, CJ; Cunningham-Rundles, C; Orange, JS; Torgerson, TR; Verbsky, JW; et al.(2015). A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay). Journal of Clinical Immunology, 35(6), 573-582. doi: 10.1007/s10875-015-0184-y. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/6h10h6f8
© 2015, The Author(s). Purpose: To develop an assay to quantify serum immunoglobulin (IgG, IgM, IgA) levels using dried blood spots (DBS) obtained on collection cards to be used as a tool for targeted screening for hypogammaglobulinemia. Methods: DB
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a38c97dfa01493fc76968eaa7ec1a211
http://europepmc.org/articles/PMC4572045
Zobrazit plný text záznamu
9
Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases
Autor: Werner Engl, Christopher J. Rabbat, Sudhir Gupta, Kenneth Paris, I. Hussain, Mark R. Stein, Barbara McCoy, Leman Yel
Publikováno v: Annals of Allergy, Asthma & Immunology. 123:271-279.e1
Background The subcutaneous immune globulin (SCIG) 20% product, Ig20Gly, was shown to be efficacious and well tolerated in 2 phase 2/3 North American and European studies at infusion volumes up to 60 mL/site and rates up to 60 mL/h/site in patients w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85cbec84a75cf5edd752a3f56d5bc5d2
https://doi.org/10.1016/j.anai.2019.06.004
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje